The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies

The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies

BackgroundAltered gut microbiome (GM) composition has been established in Parkinson’s disease (PD). However, few studies have longitudinally investigated the GM in PD, or the impact of device-assisted therapies.ObjectivesTo investigate the temporal stability of GM profiles from PD patients on standa...

Full description

Bibliographic Details
Main Authors: Michal Lubomski, Xiangnan Xu, Andrew J. Holmes, Samuel Muller, Jean Y. H. Yang, Ryan L. Davis, Carolyn M. Sue
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Aging Neuroscience
Subjects:
gut microbiota
gastrointestinal microbiome
longitudinal
progression
device-assisted therapies
levodopa-carbidopa intestinal gel
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2022.875261/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2022.875261/full

Similar Items